1. Home
  2. RPID

as of 01-07-2026 11:03am EST

$3.21
$0.17
-5.03%
Stocks Health Care Medical Specialities Nasdaq

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

Founded: 2006 Country:
United States
United States
Employees: N/A City: LEXINGTON
Market Cap: 178.6M IPO Year: 2021
Target Price: $8.00 AVG Volume (30 days): 156.0K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.00 EPS Growth: N/A
52 Week Low/High: $0.98 - $4.50 Next Earning Date: 02-27-2026
Revenue: $30,523,000 Revenue Growth: 16.63%
Revenue Growth (this year): 19.36% Revenue Growth (next year): 21.48%

AI-Powered RPID Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 17 hours ago

AI Recommendation

hold
Model Accuracy: 64.00%
64.00%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Rapid Micro Biosystems Inc. News

RPID Breaking Stock News: Dive into RPID Ticker-Specific Updates for Smart Investing

All RPID News

Share on Social Networks: